Save your place

Sign in to WhoBought

Please try again later.

Spyre Therapeutics, Inc. (SYRE) institutional ownership

Market cap$981M SectorHealthcare
Funds holding · Q1 2026
175
reported SYRE position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
116 buyers · 59 sellers

Spyre Therapeutics, Inc. (SYRE) price and institutional activity

Dates

Q1 2026

$0 bought by 116 investors
JPMorgan Chase & CoCaligan Partners LP +114 more
$0 sold by 59 investors
Capital International InvestorsDeerfield Management Company, L.P. +57 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Spyre Therapeutics, Inc. (SYRE) institutional activity · 175

Investor Type Est. change Change Δ Own Date
Capital International Investors · Reduced
Change −1.7M Date Q1 2026
Capital International Investors Reduced· Q1 2026 −1.7M Q1 2026
JPMorgan Chase & Co · Added
Change +916K Date Q1 2026
JPMorgan Chase & Co Added· Q1 2026 +916K Q1 2026
Caligan Partners LP · New
Change +878K Date Q1 2026
Caligan Partners LP New· Q1 2026 +878K Q1 2026
Bank of America Corp · Added
Change +808K Date Q1 2026
Bank of America Corp Added· Q1 2026 +808K Q1 2026
Perceptive Advisors LLC · Added
Change +714K Date Q1 2026
Perceptive Advisors LLC Added· Q1 2026 +714K Q1 2026
Deerfield Management Company, L.P. · Exited
Change −711K Δ Own −100.0% Date Q1 2026
Deerfield Management Company, L.P. Exited· Q1 2026 −711K −100.0% Q1 2026
Braidwell LP · Reduced
Change −702K Date Q1 2026
Braidwell LP Reduced· Q1 2026 −702K Q1 2026
Point72 Asset Management, L.P. · Exited
Change −662K Δ Own −100.0% Date Q1 2026
Point72 Asset Management, L.P. Exited· Q1 2026 −662K −100.0% Q1 2026
Paradigm Biocapital Advisors LP · Added
Change +490K Date Q1 2026
Paradigm Biocapital Advisors LP Added· Q1 2026 +490K Q1 2026
Commodore Capital LP · Reduced
Change −476K Date Q1 2026
Commodore Capital LP Reduced· Q1 2026 −476K Q1 2026
Capital World Investors · Added
Change +466K Date Q1 2026
Capital World Investors Added· Q1 2026 +466K Q1 2026
Pictet Asset Management Holding SA · Reduced
Change −422K Date Q1 2026
Pictet Asset Management Holding SA Reduced· Q1 2026 −422K Q1 2026
Samlyn Capital, LLC · New
Change +397K Date Q1 2026
Samlyn Capital, LLC New· Q1 2026 +397K Q1 2026
State Street · Added
Change +344K Date Q1 2026
State Street Added· Q1 2026 +344K Q1 2026
Adar1 Capital Management, LLC · Added
Change +304K Date Q1 2026
Adar1 Capital Management, LLC Added· Q1 2026 +304K Q1 2026
Data through Q1 2026 · filed Jun 4, 2026
15 of 175

Famous investor activity in Spyre Therapeutics, Inc. (SYRE)

Spyre Therapeutics, Inc. (SYRE) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Burrows Scott L. · Officer 2 operations −$658K
Price $87.55–$88.37 Qty −8K Owned 98K ΔOwn −7.1% Trade date Jul 1, 2026 Filed date Jul 2, 2026
Burrows Scott L. Officer 2 operations $87.55–$88.37 −8K −$658K 98K −7.1% Jul 1, 2026 Jul 2, 2026
Burrows Scott L. · Officer 2 operations 0
Price $14.50 Owned 352K Trade date Jul 1, 2026 Filed date Jul 2, 2026
Burrows Scott L. Officer 2 operations $14.50 0 352K Jul 1, 2026 Jul 2, 2026
Sloan Sheldon · Officer 2 operations −$731K
Price $87.52–$88.34 Qty −8K Owned 0 ΔOwn −100.0% Trade date Jul 1, 2026 Filed date Jul 2, 2026
Sloan Sheldon Officer 2 operations $87.52–$88.34 −8K −$731K 0 −100.0% Jul 1, 2026 Jul 2, 2026
Sloan Sheldon · Officer 2 operations 0
Price $27.46 Owned 305K Trade date Jul 1, 2026 Filed date Jul 2, 2026
Sloan Sheldon Officer 2 operations $27.46 0 305K Jul 1, 2026 Jul 2, 2026
Turtle Cameron · Director 3 operations −$1.3M
Price $87.44–$88.91 Qty −15K Owned 583K ΔOwn −2.5% Trade date Jul 1, 2026 Filed date Jul 2, 2026
Turtle Cameron Director 3 operations $87.44–$88.91 −15K −$1.3M 583K −2.5% Jul 1, 2026 Jul 2, 2026
Burrows Scott L. · Officer 2 operations −$1.3M
Price $87.12–$87.14 Qty −15K Owned 98K ΔOwn −13.3% Trade date Jun 25, 2026 Filed date Jun 26, 2026
Burrows Scott L. Officer 2 operations $87.12–$87.14 −15K −$1.3M 98K −13.3% Jun 25, 2026 Jun 26, 2026
Burrows Scott L. · Officer 2 operations 0
Price $14.50 Owned 360K Trade date Jun 25, 2026 Filed date Jun 26, 2026
Burrows Scott L. Officer 2 operations $14.50 0 360K Jun 25, 2026 Jun 26, 2026
Fairmount Funds Management LLC · Director Sell −$400M
Price $85.31 Qty −4.7M Owned 0 ΔOwn −100.0% Trade date Jun 23, 2026 Filed date Jun 23, 2026
Fairmount Funds Management LLC Director Sell $85.31 −4.7M −$400M 0 −100.0% Jun 23, 2026 Jun 23, 2026
Fairmount Funds Management LLC · Director 2 operations 650K
Owned 0 Trade date Jun 23, 2026 Filed date Jun 23, 2026
Fairmount Funds Management LLC Director 2 operations 650K 0 Jun 23, 2026 Jun 23, 2026
Henderson Michael Thomas · Director Sell −$2.0M
Price $100.00 Qty −20K Owned 69K ΔOwn −22.6% Trade date Jun 22, 2026 Filed date Jun 23, 2026
Henderson Michael Thomas Director Sell $100.00 −20K −$2.0M 69K −22.6% Jun 22, 2026 Jun 23, 2026
Sloan Sheldon · Officer Sell −$625K
Price $75.00 Qty −8K Owned 0 Trade date Jun 3, 2026 Filed date Jun 3, 2026
Sloan Sheldon Officer Sell $75.00 −8K −$625K 0 Jun 3, 2026 Jun 3, 2026
Sloan Sheldon · Officer 2 operations 0
Price $27.46 Owned 313K Trade date Jun 3, 2026 Filed date Jun 3, 2026
Sloan Sheldon Officer 2 operations $27.46 0 313K Jun 3, 2026 Jun 3, 2026
Turtle Cameron · Director 3 operations −$1.1M
Price $69.40–$71.38 Qty −15K Owned 598K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Turtle Cameron Director 3 operations $69.40–$71.38 −15K −$1.1M 598K Jun 1, 2026 Jun 3, 2026
Burrows Scott L. · CFO 3 operations −$533K
Price $69.75–$72.06 Qty −8K Owned 98K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Burrows Scott L. CFO 3 operations $69.75–$72.06 −8K −$533K 98K Jun 1, 2026 Jun 3, 2026
Burrows Scott L. · CFO 2 operations 0
Price $14.50 Owned 375K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Burrows Scott L. CFO 2 operations $14.50 0 375K Jun 1, 2026 Jun 3, 2026
15 of 45
15 of 45 Sign in to continue to older insider transactions.

Spyre Therapeutics, Inc. (SYRE) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
FMR LLC 7.6M
% of shares outstanding 15.0% Filing date Nov 12, 2024
FMR LLC 7.6M 15.0% Nov 12, 2024
Fairmount Funds Management LLC 4.0M
% of shares outstanding 10.0% Filing date Apr 25, 2024
Fairmount Funds Management LLC 4.0M 10.0% Apr 25, 2024
Deutsch Peter E. 3.6M
% of shares outstanding 7.0% Filing date Oct 23, 2024
Deutsch Peter E. 3.6M 7.0% Oct 23, 2024
Rtw Investments, LP 2.2M
% of shares outstanding 6.2% Filing date Feb 14, 2024
Rtw Investments, LP 2.2M 6.2% Feb 14, 2024
Venrock Healthcare Capital Partners Iii, L.P. 2.7M
% of shares outstanding 5.3% Filing date Nov 14, 2024
Venrock Healthcare Capital Partners Iii, L.P. 2.7M 5.3% Nov 14, 2024
Blackrock, Inc. 2.7M
% of shares outstanding 5.2% Filing date Nov 8, 2024
Blackrock, Inc. 2.7M 5.2% Nov 8, 2024
Perceptive Advisors LLC 4.3M
% of shares outstanding 5.0% Filing date Apr 22, 2026
Perceptive Advisors LLC 4.3M 5.0% Apr 22, 2026
Commodore Capital LP 2.0M
% of shares outstanding 3.9% Filing date Nov 14, 2024
Commodore Capital LP 2.0M 3.9% Nov 14, 2024
8 of 19

Spyre Therapeutics, Inc. (SYRE) ownership FAQ

Who owns SYRE?

175 reporting institutions disclosed SYRE position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.